Fortress Biotech, Inc. (FBIO) Income Tax Expense (Benefit) USD 2015 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Fortress Biotech, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2015 to 2023.
  • Fortress Biotech, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $0.000.
  • Fortress Biotech, Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was $521 K, a 16% increase year-over-year.
  • Fortress Biotech, Inc. annual Income Tax Expense (Benefit) for 2023 was $521 K, a 16% increase from 2022.
  • Fortress Biotech, Inc. annual Income Tax Expense (Benefit) for 2022 was $449 K, a 5.07% decline from 2021.
  • Fortress Biotech, Inc. annual Income Tax Expense (Benefit) for 2021 was $473 K, a 5.4% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $521 K +$72 K +16% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $449 K -$24 K -5.07% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $473 K -$27 K -5.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $500 K +$500 K Jan 1, 2020 Dec 31, 2020 10-K 2023-03-31
2019 $0 $0 Jan 1, 2019 Dec 31, 2019 10-K/A 2021-04-09
2018 $0 -$1.51 M -100% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $1.51 M +$1.51 M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 $0 $0 Jan 1, 2016 Dec 31, 2016 10-K 2018-03-16
2015 $0 Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.